Decreased fidelity in replicating CpG methylation patterns in cancer cells
- PMID: 15665274
Decreased fidelity in replicating CpG methylation patterns in cancer cells
Abstract
The unmethylated or methylated status of individual CpG sites is faithfully copied into daughter cells. Here, we analyzed the fidelity in replicating their methylation statuses in cancer cells. A single cell was clonally expanded, and methylation statuses of individual CpG sites were determined for an average of 12.5 DNA molecules obtained from the expanded population. By counting the deviation from the original methylation patterns inferred, the number of errors was measured. The analysis was done in four gastric cancer cell lines for five CpG islands (CGI), and repeated six times (total 1,495 clones sequenced). HSC39 and HSC57 showed error rates <1.0 x 10(-3) errors per site per generation (99.90-100% fidelity) for all the five CGIs. In contrast, AGS showed significantly elevated error rates, mainly due to increased de novo methylation, in three CGIs (1.6- to 3.2-fold), and KATOIII showed a significantly elevated error rate in one CGI (2.2-fold). By selective amplification of fully methylated DNA molecules by methylation-specific PCR, those were stochastically detected in KATOIII and AGS but never in HSC39 and HSC57. When methylation of entire CGIs was examined for eight additional CGIs, KATOIII and AGS had frequent methylation, whereas HSC39 and HSC57 had few. KATOIII and AGS had four and eight times, respectively, as high expression levels of DNMT3B as HSC39. These data showed that some cancer cells have decreased fidelity in replicating methylation patterns in some CGIs, and that the decrease could lead to methylation of the entire CGIs.
Similar articles
-
Decreased fidelity in replicating DNA methylation patterns in cancer cells leads to dense methylation of a CpG island.Curr Top Microbiol Immunol. 2006;310:199-210. doi: 10.1007/3-540-31181-5_10. Curr Top Microbiol Immunol. 2006. PMID: 16909912 Review.
-
Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.Cancer Lett. 2007 May 8;249(2):178-87. doi: 10.1016/j.canlet.2006.08.014. Epub 2006 Sep 12. Cancer Lett. 2007. PMID: 16971039
-
A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.Genome Res. 2004 Feb;14(2):247-66. doi: 10.1101/gr.1351604. Genome Res. 2004. PMID: 14762061 Free PMC article.
-
Fidelity of the methylation pattern and its variation in the genome.Genome Res. 2003 May;13(5):868-74. doi: 10.1101/gr.969603. Genome Res. 2003. PMID: 12727906 Free PMC article.
-
CpG islands--'a rough guide'.FEBS Lett. 2009 Jun 5;583(11):1713-20. doi: 10.1016/j.febslet.2009.04.012. Epub 2009 Apr 18. FEBS Lett. 2009. PMID: 19376112 Review.
Cited by
-
Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.Oncotarget. 2016 Oct 18;7(42):68242-68252. doi: 10.18632/oncotarget.11921. Oncotarget. 2016. PMID: 27626164 Free PMC article.
-
Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.Cancer Med. 2015 Oct;4(10):1536-46. doi: 10.1002/cam4.507. Epub 2015 Aug 15. Cancer Med. 2015. PMID: 26276761 Free PMC article.
-
Cytostatic drug treatment causes seeding of gene promoter methylation.Eur J Cancer. 2007 Mar;43(5):947-54. doi: 10.1016/j.ejca.2006.12.003. Epub 2007 Jan 22. Eur J Cancer. 2007. PMID: 17236756 Free PMC article.
-
The stem cell population of the human colon crypt: analysis via methylation patterns.PLoS Comput Biol. 2007 Mar 2;3(3):e28. doi: 10.1371/journal.pcbi.0030028. Epub 2007 Jan 2. PLoS Comput Biol. 2007. PMID: 17335343 Free PMC article.
-
Methylation kinetics and CpG-island methylator phenotype status in colorectal cancer cell lines.Biol Direct. 2013 Jun 11;8:14. doi: 10.1186/1745-6150-8-14. Biol Direct. 2013. PMID: 23758948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources